166 related articles for article (PubMed ID: 28947744)
1. Therapeutic Effectiveness of Anti-RAGE Antibody Administration in a Rat Model of Crush Injury.
Matsumoto H; Matsumoto N; Shimazaki J; Nakagawa J; Imamura Y; Yamakawa K; Yamada T; Ikeda M; Hiraike H; Ogura H; Shimazu T
Sci Rep; 2017 Sep; 7(1):12255. PubMed ID: 28947744
[TBL] [Abstract][Full Text] [Related]
2. Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury.
Shimazaki J; Matsumoto N; Ogura H; Muroya T; Kuwagata Y; Nakagawa J; Yamakawa K; Hosotsubo H; Imamura Y; Shimazu T
Shock; 2012 Jun; 37(6):634-8. PubMed ID: 22392147
[TBL] [Abstract][Full Text] [Related]
3. Anti-high-mobility group box-1 (HMGB1) mediates the apoptosis of alveolar epithelial cells (AEC) by receptor of advanced glycation end-products (RAGE)/c-Jun N-terminal kinase (JNK) pathway in the rats of crush injuries.
Zhang BF; Song W; Wang J; Wen PF; Zhang YM
J Orthop Surg Res; 2022 Jan; 17(1):20. PubMed ID: 35033142
[TBL] [Abstract][Full Text] [Related]
4. RAGE inhibition reduces acute lung injury in mice.
Blondonnet R; Audard J; Belville C; Clairefond G; Lutz J; Bouvier D; Roszyk L; Gross C; Lavergne M; Fournet M; Blanchon L; Vachias C; Damon-Soubeyrand C; Sapin V; Constantin JM; Jabaudon M
Sci Rep; 2017 Aug; 7(1):7208. PubMed ID: 28775380
[TBL] [Abstract][Full Text] [Related]
5. Anti-RAGE antibody attenuates isoflurane-induced cognitive dysfunction in aged rats.
Shi C; Yi D; Li Z; Zhou Y; Cao Y; Sun Y; Chui D; Guo X
Behav Brain Res; 2017 Mar; 322(Pt A):167-176. PubMed ID: 28115220
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Matrix Metalloproteinase-9 Protects against Sepsis-Induced Acute Lung Injury via Promoting the Release of Soluble Receptor for Advanced Glycation End Products.
Zhang H; Mao YF; Zhao Y; Xu DF; Wang Y; Xu CF; Dong WW; Zhu XY; Ding N; Jiang L; Liu YJ
Oxid Med Cell Longev; 2021; 2021():8889313. PubMed ID: 33628393
[TBL] [Abstract][Full Text] [Related]
7. Anti-RAGE antibody selectively blocks acute systemic inflammatory responses to LPS in serum, liver, CSF and striatum.
Gasparotto J; Ribeiro CT; Bortolin RC; Somensi N; Fernandes HS; Teixeira AA; Guasselli MOR; Agani CAJO; Souza NC; Grings M; Leipnitz G; Gomes HM; de Bittencourt Pasquali MA; Dunkley PR; Dickson PW; Moreira JCF; Gelain DP
Brain Behav Immun; 2017 May; 62():124-136. PubMed ID: 28088642
[TBL] [Abstract][Full Text] [Related]
8. The Beneficial Effects of ETS-GS, a Novel Vitamin E Derivative, on a Rat Model of Crush Injury.
Nakagawa J; Matsumoto N; Nakane Y; Yamakawa K; Yamada T; Matsumoto H; Shimazaki J; Imamura Y; Ogura H; Jin T; Shimazu T
Shock; 2016 Dec; 46(6):681-687. PubMed ID: 27355403
[TBL] [Abstract][Full Text] [Related]
9. [Effect of treatment with anti-receptor for advanced glycation end products antibody on multiple organ dysfunction and mortality in rats after severe thermal injury].
Zhang XT; Yao YM; Huang LF; Yu Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Sep; 20(9):523-6. PubMed ID: 18786308
[TBL] [Abstract][Full Text] [Related]
10. Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury.
Zhang H; Tasaka S; Shiraishi Y; Fukunaga K; Yamada W; Seki H; Ogawa Y; Miyamoto K; Nakano Y; Hasegawa N; Miyasho T; Maruyama I; Ishizaka A
Am J Respir Crit Care Med; 2008 Aug; 178(4):356-62. PubMed ID: 18535257
[TBL] [Abstract][Full Text] [Related]
11. Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury.
Lee S; Piao C; Kim G; Kim JY; Choi E; Lee M
Eur J Pharm Sci; 2018 Mar; 114():275-284. PubMed ID: 29292016
[TBL] [Abstract][Full Text] [Related]
12. Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.
Smit PJ; Guo WA; Davidson BA; Mullan BA; Helinski JD; Knight PR
J Surg Res; 2014 Sep; 191(1):214-23. PubMed ID: 24814199
[TBL] [Abstract][Full Text] [Related]
13. Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome.
Selejan SR; Linz D; Tatu AM; Hohl M; Speer T; Ewen S; Mahfoud F; Kindermann I; Zamyatkin O; Kazakov A; Laufs U; Böhm M
J Mol Cell Cardiol; 2018 Sep; 122():34-46. PubMed ID: 30096408
[TBL] [Abstract][Full Text] [Related]
14. Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury.
Miyagawa T; Iwata Y; Oshima M; Ogura H; Sato K; Nakagawa S; Yamamura Y; Kamikawa Y; Miyake T; Kitajima S; Toyama T; Hara A; Sakai N; Shimizu M; Furuichi K; Munesue S; Yamamoto Y; Kaneko S; Wada T
Biol Open; 2022 Jan; 11(1):. PubMed ID: 34812852
[TBL] [Abstract][Full Text] [Related]
15. RAGE blockade and hepatic microcirculation in experimental endotoxaemic liver failure.
Kuhla A; Norden J; Abshagen K; Menger MD; Vollmar B
Br J Surg; 2013 Aug; 100(9):1229-39. PubMed ID: 23804133
[TBL] [Abstract][Full Text] [Related]
16. All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.
Oczypok EA; Perkins TN; Oury TD
Paediatr Respir Rev; 2017 Jun; 23():40-49. PubMed ID: 28416135
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody against the receptor for advanced glycation end products attenuates inflammatory and neuropathic pain in the mouse.
Brederson JD; Strakhova M; Mills C; Barlow E; Meyer A; Nimmrich V; Leddy M; Simler G; Schmidt M; Jarvis M; Lacy S
Eur J Pain; 2016 Apr; 20(4):607-14. PubMed ID: 26392119
[TBL] [Abstract][Full Text] [Related]
18. Immune neutralization of the receptor for advanced glycation end products reduce liver oxidative damage induced by an acute systemic injection of lipopolysaccharide.
Tiefensee Ribeiro C; Gasparotto J; Teixeira AA; Portela LVC; Flores VNL; Moreira JCF; Gelain DP
J Biochem; 2018 Jun; 163(6):515-523. PubMed ID: 29365096
[TBL] [Abstract][Full Text] [Related]
19. Soluble form of the receptor for advanced glycation end-products attenuates inflammatory pathogenesis in a rat model of lipopolysaccharide-induced lung injury.
Izushi Y; Teshigawara K; Liu K; Wang D; Wake H; Takata K; Yoshino T; Takahashi HK; Mori S; Nishibori M
J Pharmacol Sci; 2016 Apr; 130(4):226-34. PubMed ID: 27038888
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection.
Lutterloh EC; Opal SM; Pittman DD; Keith JC; Tan XY; Clancy BM; Palmer H; Milarski K; Sun Y; Palardy JE; Parejo NA; Kessimian N
Crit Care; 2007; 11(6):R122. PubMed ID: 18042296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
